Tivoxavir marboxil is an investigational new drug that is being evaluated by Traws Pharma, Inc. for the treatment of influenza. It is a cap-dependent endonuclease inhibitor.
Chemistry
Tivoxavir marboxil the prodrug form of tivoxavir. The carbonate containing sidechain (marboxil) is cleaved enzymatically to yield the active form of the drug tivoxavir.
References